Search

Search Constraints

You searched for: Author/Creator Neumann, Ulf

Search Results

1. [O2–17–05]: RATIONALE FOR CNP520 DOSE SELECTION FOR THE PIVOTAL CLINICAL PROGRAM IN PRECLINICAL AD. (1st July 2017)

2. [P1–051]: RESULTS FROM A 3‐MONTH STUDY IN HEALTHY SUBJECTS AGED 60 YEARS WITH THE BACE INHIBITOR CNP520. (1st July 2017)

3. [P2–058]: PREVENTION OF CEREBRAL AMYLOID ANGIOPATHY IN A MOUSE MODEL OF HEREDITARY CEREBRAL HEMORRAGE WITH AMYLOIDOSIS‐DUTCH TYPE. (1st July 2017)

4. A Pooled Analysis of Three Randomized Phase I/IIa Clinical Trials Confirms Absence of a Clinically Relevant Effect on the QTc Interval by Umibecestat. Issue 6 (23rd July 2020)

5. A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV-Positive Liver Allograft Recipients. (27th May 2012)

6. A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV-Positive Liver Allograft Recipients. (28th May 2012)

7. ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157. (1st November 2017)

10. CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma. Issue 1 (December 2017)